In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs

The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires treatments with rapid clinical translatability. Here we develop a multi-target and multi-ligand virtual screening method to identify FDA-approved drugs with potential activity against SARS-CoV-2 at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Wallace K. B., Olson, Keith M., Wotring, Jesse W., Sexton, Jonathan Z., Carlson, Heather A., Traynor, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963407/
https://www.ncbi.nlm.nih.gov/pubmed/35351926
http://dx.doi.org/10.1038/s41598-022-08320-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963407/
https://www.ncbi.nlm.nih.gov/pubmed/35351926
http://dx.doi.org/10.1038/s41598-022-08320-y

Ejemplares similares